How do protozoan parasites survive inside macrophages?

Parasitology Today

Volumn 15, Issue 1, 1999, Pages 22-28

  Bogdan, Christian ^a   Rollinghoff M ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL PROLIFERATION; CELL VIABILITY; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; LEISHMANIA; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PROTOZOAL INFECTION; PROTOZOON; REVIEW; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI;

ANIMALS; MACROPHAGES; PROTOZOA; PROTOZOAN INFECTIONS;

CHRISTIA; PROTOZOA; TOXOPLASMA GONDII; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0032991895     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(98)01362-3     Document Type: Review

References (70)

1. Mauël J. Intracellular survival of protozoan parasites with special reference to Leishmania spp, Toxoplasma gondii, and Trypanosoma cruzi. Adv. Parasitol. 38:1996;1-51.
2. 2+. Parasitol. Today. 12:1996;145-150.
3. Bogdan C., Röllinghoff M. The immune response to Leishmania: mechanisms of parasite control and evasion. Int. J. Parasitol. 28:1998;121-134.
4. Dubremetz J.F. Host cell invasion by Toxoplasma gondii. Trends Microbiol. 6:1998;27-30.
5. Rittig M.G.et al. Coiling phagocytosis of trypanosomatids and fungal cells. Infect. Immun. 66:1998;4331-4339.
6. Desjardins M., Descoteaux A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185:1997;2061-2068.
7. Joshi P.B.et al. Targeted deletion of Leishmania major genes encoding developmental stage-specific leishmaniolysin (gp63). Mol. Microbiol. 27:1998;519-530.
8. Andrews N.W. From lysosomes into the cytosol: the intracellular pathway of Trypanosoma cruzi. Braz. J. Med. Biol. Res. 27:1994;471-475.
9. Ming M.et al. Trypanosome invasion by mammalian cells requires activation of the TGF-β signalling pathways. Cell. 82:1995;287-296.
10. Dobrowolski J.M., Sibley L.D. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell. 84:1996;933-939.
11. Fadul C.E.et al. Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes. Infect. Immun. 63:1995;4290-4294.
12. Bogdan C. Of microbes, macrophages and NO. Behring Inst. Res. Commun. 99:1997;58-72.
13. Wei X-Q.et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
14. Scharton-Kersten T.M.et al. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1997;1261-1273.
15. Diefenbach A.et al. Type 1 interferon (IFN-α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:1998;77-87.
16. Plasman N.et al. Interferon-γ-activated immature macrophages exhibit a high Trypanosoma cruzi infection rate associated with a low production of both nitric oxide and tumor necrosis factor alpha. Parasitol. Res. 80:1994;554-558.
17. Silva J.S.et al. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection by inducing nitric oxide production in infected gamma-interferon activated macrophages. Infect. Immun. 63:1995;4862-4867.
18. Proudfoot L.et al. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. U. S. A. 93:1996;10984-10989.
19. Camargo M.M.et al. Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-γ-primed macrophages. J. Immunol. 159:1997;6131-6139.
20. Pakianathan D.R., Kuhn R.E. Trypanosoma cruzi affects nitric oxide production by murine peritoneal macrophages. J. Parasitol. 80:1994;432-437.
21. Ho J.L.et al. Interleukin-3 induces antimicrobial activity against Leishmania amazonensis and Trypanosoma cruzi and tumoricidal activity in human peripheral blood-derived macrophages. Infect. Immun. 60:1992;1984-1993.
22. Murray H.W., Teitelbaum R.F. L-Arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165:1992;513-517.
23. Däubener W., Hadding U. Cellular immune reactions directed against Toxoplasma gondii with special emphasis on the central nervous system. Med. Microbiol. Immunol. 185:1997;195-206.
24. Zychlinsky A., Sansonetti P.J. Apoptosis as a proinflammatory event: what can we learn from bacteria-induced cell death? Trends Microbiol. 5:1997;201-204.
25. Moore K.J., Matlashewski G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol. 152:1994;2930-2937.
26. Nash P.B.et al. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J. Immunol. 160:1998;1824-1830.
27. Hisaeda H.et al. Heat shock protein 65 induced by γδ T cells prevents apoptosis of macrophages and contributes to host defense in mice infected with Toxoplasma gondii. J. Immunol. 159:1997;2375-2381.
28. Freire-de-Lima C.G.et al. Pro-apoptotic activity of a Trypanosoma cruzi ceramide-containing glycolipid turned on in host macrophages by interferon-γ J. Immunol. 161:1998;4909-4916.
29. Bogdan C.et al. Invasion, control, and persistence of Leishmania parasites. Curr. Opin. Immunol. 8:1996;517-525.
30. Brenner Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114:1997;103-110.
31. Bogdan C., Nathan C. Modulation of macrophage function by transforming growth factor-β, interleukin 4 and interleukin 10. Ann. New York Acad. Sci. 685:1993;713-739.
32. Barral A.et al. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. U. S. A. 90:1993;3442-3446.
33. Stenger S.et al. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:1994;783-793.
34. Rodrigues V.et al. Transforming growth factor-β and immunosuppression in experimental visceral leishmaniasis. Infect. Immun. 66:1998;1233-1236.
35. Silva J.S.et al. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β). J. Exp. Med. 174:1991;539-545.
36. Bermudez L.E.et al. Infection of murine macrophages with Toxoplasma gondii is associated with the release of transforming growth factor β and downregulation of expression of tumor necrosis factor receptors. Infect. Immun. 61:1993;4126-4130.
37. Carrera L.et al. Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:1996;515-526.
38. Sartori A.et al. Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. J. Immunol. 159:1997;2849-2857.
39. Fischer H.G.et al. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Eur. J. Immunol. 27:1997;1539-1548.
40. Barral-Netto M.et al. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science. 257:1992;545-548.
41. Hunter C.A.et al. Transforming growth factor-β inhibits interleukin-12-induced production of interferon-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:1995;994-1000.
42. Haque S.et al. Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin 2 production and macrophage-mediated inhibitory effects. Infect. Immun. 62:1994;2908-2916.
43. Cardillo F.et al. Regulation of Trypanosoma cruzi infection in mice by gamma-interferon and interleukin-10: role of NK cells. Infect. Immun. 64:1996;128-134.
44. Abrahamsohn I.A., Coffman R.L. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 84:1996;231-244.
45. Hunter C.A.et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158:1997;3311-3316.
46. Reed S.G.et al. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 153:1994;3135-3140.
47. Deckert-Schlucaeter M.et al. Interleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis. J. Neuroimmunol. 76:1997;167-176.
48. Neyer L.E.et al. Role of IL-10 in regulation of T-cell- dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65:1997;1675-1682.
49. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α J. Immunol. 157:1996;798-805.
50. Vieira L.Q.et al. Infection of Leishmania major induces interleukin 12 production in vivo. Immunol. Lett. 40:1994;157-161.
51. Weinheber N.et al. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur. J. Immunol. 28:1998;2467-2477.
52. von Stebut E.et al. Uptake of Leishmania major amastigotes results in activation and interleukin-12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188:1998;1547-1552.
53. + T cells during initiation of infection. J. Exp. Med. 179:1994;447-456.
54. Gorak P.M.A.et al. Dendritic cells, but not macrophages produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28:1998;687-695.
55. Belkaid Y.et al. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol. 28:1998;1389-1400.
56. Bacellar O.et al. Interleukin-12 restores interferon-γ production and cytotoxic responses in visceral leishmaniasis. J. Infect. Dis. 173:1996;1515-1518.
57. Probst P.et al. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-α production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur. J. Immunol. 27:1997;2634-2642.
58. Reis e Sousa C.et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin-12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 11:1997;1819-1829.
59. Frosch S.et al. Trypanosoma cruzi is a potent inducer of interleukin-12 production in macrophages. Med. Microbiol. Immunol. 185:1996;189-193.
60. de Diego J.et al. Alteration of macrophage function by a Trypanosoma cruzi membrane mucin. J. Immunol. 159:1997;4983-4989.
61. Kaye P.M. Costimulation and the regulation of antimicrobial immunity. Immunol. Today. 16:1995;423-427.
62. McMahon-Pratt D.et al. Leishmania amastigote target antigens: the challenge of a stealthy intracellular parasite. Parasitol. Today. 14:1998;31-34.
63. La Flamme A.C.et al. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation. Eur. J. Immunol. 27:1997;3085-3094.
64. Frosch S.et al. Infection with Trypanosoma cruzi selectively upregulates B7-2 molecules on macrophages and enhances their costimulatory activity. Infect. Immun. 65:1997;971-979.
65. + T lymphocytes from infected hosts. J. Immunol. 160:1998;1313-1319.
66. Lucaeder C.G.K.et al. Down-regulation of MHC class II molecules and inability to upregulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin. Exp. Immunol. 112:1998;308-316.
67. Subauste C.S.et al. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen. J. Immunol. 160:1998;1831-1840.
68. + T cell unresponsiveness during acute Toxoplasma gondii infection in mice. Int. Immunol. 8:1996;887-896.
69. Beverly S.M., Turco S.J. Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol. 6:1998;35-44.
70. Stenger S.et al. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183:1996;1501-1514.